ashutoshjhabuz@gmail.com

Unexpected China Factory Contraction Confirms Deflationary Headwinds, Overcapacity

Economics / Leave a Comment

Anti-globalists and China bulls fiercely resist the idea that China can do much of any wrong. And China is certainly better led that the US and has had a simply extraordinary economic run. However, China’s leaders, from Xi Jinpeng on down, are admitting to something they had fiercely denied was happening: that China’s answer to […]

Unexpected China Factory Contraction Confirms Deflationary Headwinds, Overcapacity Read More »

Eli Lilly’s Mounjaro shows similar heart health benefits as Trulicity

Stock Market / Leave a Comment

Mounjaro manufactured by Eli Lilly and Company packaging is seen in this illustration photo taken in a pharmacy in Krakow, Poland on April 9, 2024. Nurphoto | Nurphoto | Getty Images Eli Lilly on Thursday said its blockbuster diabetes drug Mounjaro showed heart health benefits in a late-stage trial directly comparing it to the company’s

Eli Lilly’s Mounjaro shows similar heart health benefits as Trulicity Read More »

Consumers Are Footing the Bill for AI’s Insatiable Appetite for Energy

Economics / Leave a Comment

Yves here. Perhaps most readers were aware, but I have to admit that even with all of the considerable alarm about the energy staggering demands of AI, I had missed a key point. I had thought the ginormous energy-eating was due to needing to training set demands, that it was generally understood that the widespread

Consumers Are Footing the Bill for AI’s Insatiable Appetite for Energy Read More »

Covid vaccine makers Moderna BioNTech stocks, mRNA strategies diverge

Stock Market / Leave a Comment

A researcher works in the lab at the Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024.  Adam Glanzman | Bloomberg | Getty Images The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies are on different paths. Both Moderna and BioNTech helped pioneer mRNA, or

Covid vaccine makers Moderna BioNTech stocks, mRNA strategies diverge Read More »

South America’s Sovereignty Is Being Lost in Big Tech’s Clouds

Economics / Leave a Comment

Yves here. This post discusses two pet peeves of mine. One is the wooly-headed thinking and policy making around BRICS and other multi-polarity initiatives. Second is the bizarre cavalierness with which just about all organizations exhibit around control of their data. Without pre-empting its discussion, this article describes how Brazil’s plans to be among the

South America’s Sovereignty Is Being Lost in Big Tech’s Clouds Read More »

Long-COVID, Viruses and ‘Zombie’ Cells: New Research Looks for Links to Chronic Fatigue and Brain Fog

Economics / Leave a Comment

Yves here. Long Covid is oddly being more often acknowledged by the press as a pathology with high personal and societal costs, yet there also seems to be a bizarre collective resignation about it even as the number of Long Covid case continues to rise. The article below demonstrates that some researchers are making a

Long-COVID, Viruses and ‘Zombie’ Cells: New Research Looks for Links to Chronic Fatigue and Brain Fog Read More »